This was consistent with previous immunohistochemical studies on other carcinomas in which Osteopontin expression was detected in 33.3–70.0% (Ue et al, 1998; Zhang et al, 2001; Coppola et al, 2004). The gene discussed is SPP1; the disease is carcinoma.